Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Sell
10,654
-7,834
-42% -$878K ﹤0.01% 1366
2026
Q1
$1.65M Buy
18,488
+2,675
+17% +$306K 0.01% 1007
2025
Q4
$1.45M Buy
15,813
+4,236
+37% +$381K 0.01% 1028
2025
Q3
$971K Buy
11,577
+5,246
+83% +$407K 0.01% 1099
2025
Q2
$466K Buy
6,331
+1,174
+23% +$62.6K ﹤0.01% 1394
2025
Q1
$216K Sell
5,157
-2,040
-28% -$96K ﹤0.01% 1596
2024
Q4
$382K Buy
7,197
+2,325
+48% +$127K ﹤0.01% 1202
2024
Q3
$233K Buy
+4,872
New +$212K ﹤0.01% 1232

Other funds holding CCJ

&Partners's CCJ Position: Q2 2026 in Review

&Partners reduced its Cameco (CCJ) stake by 42% in Q2 2026, selling an estimated $878K and leaving 10,654 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #1366.

&Partners first reported a position in CCJ in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.65M in Q1 2026. 1,033 funds tracked by Wall St. Rank hold CCJ as of Q2 2026.

  • &Partners held 10,654 shares of Cameco worth $1.09M as of Q2 2026.
  • &Partners sold 7,834 Cameco shares in Q2 2026, an estimated $878K.
  • Cameco made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1366 holding.
  • &Partners first reported a position in Cameco in Q3 2024 and has held it in 8 quarters since.
  • &Partners's Cameco position peaked at $1.65M in Q1 2026.
  • 1,033 funds tracked by Wall St. Rank held Cameco as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.